Company intelligence / Profile preview

Everlife Asia

Singapore, Singapore

Ownership: Private
Employees: ~1000
Development stage: Other

Overview

Everlife Asia is the leading provider of diagnostic products and solutions to clinical and scientific laboratories in South and South East Asia, serving more than 250 principal brands, with direct presence in 7 countries, and nearly 1,000 employees. Everlife is focused on enabling better outcomes by improving access to laboratory, diagnostic, and scientific solutions across Asia, supported by distribution, technical service, regulatory, and manufacturing capabilities

Industry: Consumable Medical Devices

Partnerships

Distributor partnership with brands including Cytiva, Agilent, PacBio, Nanostring, Cell Signaling Technologies, Proteintech, Twist Bioscience, Quanterix, Thermo Fisher and othersMinority investment partnerships: Cure Capital (minority investor)

Beyond the preview

Go deeper on Everlife Asia.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Everlife Asia.

Explore the full profile